Oramed Receives FDA Clearance for IND Application for Its Oral GLP-1 Analog Capsule

NEW YORK, Sept. 17, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for human trials of its oral GLP-1 analog capsule […]

Join our mailing list

Skip to content